(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 17.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.17%.
Anixa Biosciences's earnings in 2025 is -$12,483,000.On average, 1 Wall Street analyst forecast ANIX's earnings for 2025 to be -$13,200,713, with the lowest ANIX earnings forecast at -$13,200,713, and the highest ANIX earnings forecast at -$13,200,713.
In 2026, ANIX is forecast to generate -$12,878,745 in earnings, with the lowest earnings forecast at -$12,878,745 and the highest earnings forecast at -$12,878,745.